# FDA Inspection 1090548 - Gland Pharma Limited - May 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/826a0fc9-eaf4-4d9e-9236-b51098beb6ed
Source feed: FDA_Inspections

> FDA Inspection 1090548 for Gland Pharma Limited on May 16, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1090548
- Company Name: Gland Pharma Limited
- Inspection Date: 2019-05-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1244548 - 2024-07-25](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/acffcfce-62b6-4883-95ee-555ed8943c50)
- [FDA Inspection 1210381 - 2023-07-14](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/a827d7e0-fc10-4952-baf6-b295d8269dbc)
- [FDA Inspection 1179407 - 2022-08-25](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/d25b4f34-1b29-4a94-be87-9f1e6e0cceab)
- [FDA Inspection 1002974 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/2790d68f-af89-4d25-a23e-b35acfa506d3)
- [FDA Inspection 921536 - 2015-03-17](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/b47d8672-6428-41fd-bb87-db9406b20fe4)

Company: https://www.keypedia.com/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c